Answers are grounded in this paper and cite their sources.
Retrospective cohort study explores barriers and facilitators for lymphoedema treatment in patients, suggesting pathways for improved care.
Introduction: Patient implementation of breast cancer-related lymphoedema treatment recommendations is often considered suboptimal. This study explored patient implementation of occupational therapy breast cancer-related lymphoedema treatment recommendations and identified barriers and enablers. Method: An observational retrospective cohort study was conducted using clinical data from a tertiary hospital’s prospective surveillance model of care for early breast cancer-related lymphoedema detection and intervention. Patients who received occupational therapy were included, and implementation levels were compared above and below a 70% threshold. Results: Among 63 patients (median age = 60 years, interquartile range 47.0–70.0), 73% ( n = 46) implemented over 70% of recommendations and 29% achieved full implementation. Pain (54%, n = 34) was the main barrier, while strong support networks (63.5%, n = 40) were the leading enabler. Lower implementation was associated with receipt of taxane chemotherapy ( p = 0.030), fewer therapy interventions provided ( p < 0.001), type of tumour ( p = 0.014), lymphoedema management not seen as a patient priority ( p = 0.001) and receiving nicotine treatment ( p = 0.038). Sentinel node biopsy ( p = 0.024) and understanding the risks of poor lymphoedema management ( p = 0.019) were associated with increased patient implementation. Conclusion: Most patients implemented >70% of breast cancer-related lymphoedema treatment recommendations; however, understanding and addressing clinical and psychosocial factors could optimise implementation and improve outcomes.
No takes yet. Share an insight, caveat, or question.
Veart et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: